Beta The Briev beta is out. Free on iPhone via TestFlight — install it in under a minute.

Join the beta ↗
Briev
Live
Health

Patient distrust of Palantir’s NHS data platform could jeopardise care, watchdog warns

The NHS data watchdog says lack of public trust in Palantir’s federated data platform may undermine patient care, while the company’s UK senior vice-president Tom Watson disputes the warning.

The National Data Guardian has cautioned that eroding public confidence in Palantir’s Federated Data Platform threatens its ability to improve NHS services. The system aggregates hospital information to streamline waiting lists, operating theatre scheduling and discharge planning, and now also incorporates GP records. Since the contract’s award, opt-out requests have risen sharply, with roughly 60,000 additional patients withdrawing between mid-May and mid-July, a trend linked to recent media scrutiny.

While Palantir asserts that all data remain under NHS control in the UK, a YouGov poll found 76 % of adults deem US tech firms handling NHS data unacceptable. Former Labour deputy leader Tom Watson, appointed as Palantir’s UK senior vice-president, defended the company, accusing the watchdog of overlooking facts and of being swayed by campaign groups. The contract, worth up to £330 million over seven years, is due for renewal next year, and the decision will rest with Prime Minister Andy Burnham after parliamentary committees advised against extension.

Why it matters

Public mistrust could limit a major NHS data system, affecting patient care and future health-tech contracts.

In this story

NHS data sharingPalantirpatient trustopt-outfederated data platformpublic concernsdata sovereigntycontract renewal
Get the beta ↗